Durvalumab Enhances Survival in SCLC ...Middle East

Medscape - News
Patients with limited-stage SCLC were randomly assigned to receive durvalumab with or without tremelimumab or placebo as adjuvant therapy. Medscape Medical News

Hence then, the article about durvalumab enhances survival in sclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Durvalumab Enhances Survival in SCLC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News